Microbiology devices panel
This article was originally published in The Gray Sheet
Will evaluate a premarket approval application for "the use of a Southern blot nucleic acid hybridization assay to detect and type human papillomavirus" at an Aug. 23 meeting in Bethesda, Maryland. For more information contact Sharon Hansen at (301) 427-1096.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.